GSK, Verily-backed Galvani starts trials of bioelectronic arthritis therapy

GSK, Verily-backed Galvani starts trials of bioelectronic arthritis therapy

Submitted by admin on January 27, 2022 - 10:55am
Source: 
Pharmaforum
News Tags: 
GSK
Verily
Galvani
devices
arthritis
Headline: 
GSK, Verily-backed Galvani starts trials of bioelectronic arthritis therapy
snippet: 

The first patient has been treated with an implantable bioelectronic device developed by Galvani Therapeutics, set up by GlaxoSmithKline and Alphabet’s Verily Life Sciences in 2016.

Do Not Allow Advertisers to Use My Personal information